BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,408,804 | +62.1% | 16,880,000 | +31.1% | 0.00% | 0.0% |
| Q2 2023 | $10,121,267 | +18.3% | 12,880,000 | +11.7% | 0.00% | – |
| Q1 2023 | $8,554,851 | -31.3% | 11,530,000 | -57.4% | 0.00% | – |
| Q4 2022 | $12,458,274 | +55.8% | 27,060,000 | +100.0% | 0.00% | -100.0% |
| Q3 2022 | $7,997,000 | +25.1% | 13,530,000 | +17.3% | 0.00% | – |
| Q2 2022 | $6,390,000 | -15.0% | 11,530,000 | -8.7% | 0.00% | – |
| Q1 2022 | $7,519,000 | -37.3% | 12,630,000 | -22.1% | 0.00% | -100.0% |
| Q4 2021 | $11,985,000 | -47.8% | 16,205,000 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $22,954,000 | -5.8% | 16,605,000 | +12.2% | 0.00% | 0.0% |
| Q2 2021 | $24,375,000 | +28.6% | 14,805,000 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $18,948,000 | – | 11,480,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |